RZLT
Rezolute, Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.58
+0.88%Next report
Analyst consensus
- Next report date
- Sep 16, 2026
- EPS estimate
- -$0.13
- Revenue estimate
- —
Latest reported
- Last report date
- May 12, 2026
- EPS actual
- -$0.16
- EPS estimate
- -$0.14
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 2
- Avg surprise (4Q)
- -8.2%
- Revenue beats (12Q)
- —
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $11
- PT range
- $6.00 – $14
- Analysts
- 4
4 Buy0 Hold0 Sell
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Sep 16, 2026